ARD-885
/ Artivila Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 06, 2025
Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetic, and Food Effects of ARD-885 Film-coated Tablets in Healthy Chinese Subjects and Patients With Rheumatoid Arthritis
(clinicaltrials.gov)
- P1 | N=94 | Completed | Sponsor: Artivila (Shenzhen) Innovation Center, Ltd
New P1 trial • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
1 to 1
Of
1
Go to page
1